MUCOCUTANEOUS LEISHMANIASIS

MUCOCUTANEOUS LEISHMANIASIS was reported 122 times

MUCOCUTANEOUS LEISHMANIASIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Antileishmanial [EPC] 6 0.0155
1 Lipid-based Polyene Antifungal [EPC] 12 0.0009
2 Sulfone [EPC] 8 0.0007
3 Polyene Antifungal [EPC] 12 0.0003
4 Antimetabolite Immunosuppressant [EPC] 6 0.0003
5 Purine Antimetabolite [EPC] 13 0.0001
6 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 3 0.0001
7 Pyrimidine Synthesis Inhibitor [EPC] 5 0.0001
8 Folate Analog Metabolic Inhibitor [EPC] 42 0.0001
9 Histamine-1 Receptor Antagonist [EPC] 8 0.0001
10 Aminosalicylate [EPC] 9 0.0001
11 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 4 0.0001
12 Programmed Death Receptor-1 Blocking Antibody [EPC] 7 0.0001
13 Calcineurin Inhibitor Immunosuppressant [EPC] 9 0.0001
14 CD20-directed Cytolytic Antibody [EPC] 21 0.0001
15 Corticosteroid [EPC] 80 0.0001
16 Alkylating Drug [EPC] 12 0.0000
17 Tumor Necrosis Factor Blocker [EPC] 46 0.0000
18 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 5 0.0000
19 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
20 Antimycobacterial [EPC] 1 0.0000
21 Vitamin D [EPC] 12 0.0000
22 Vitamin B12 [EPC] 12 0.0000
23 Vitamin C [EPC] 12 0.0000
24 Azole Antifungal [EPC] 4 0.0000
25 Platinum-based Drug [EPC] 5 0.0000
26 Tetracycline-class Drug [EPC] 1 0.0000
27 Interleukin-12 Antagonist [EPC] 1 0.0000
28 Interleukin-23 Antagonist [EPC] 1 0.0000
29 Antirheumatic Agent [EPC] 1 0.0000
30 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
31 Nonsteroidal Anti-inflammatory Drug [EPC] 9 0.0000
32 Calcium [EPC] 1 0.0000
33 Expectorant [EPC] 1 0.0000